 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > Agouron Pharmaceuticals, Inc.
 |
Agouron Pharmaceuticals, Inc. |
 |
 |
 |
PROFILE |
 |
Agouron Pharmaceuticals develops drugs to treat diseases you don't like thinking about -- HIV, cancer, and the common cold. The company uses technology based on the molecular structure of proteins to create synthetic drugs. Its first commercial product, Viracept, is a protease inhibitor drug designed to fight the virus that causes AIDS. The firm also sells HIV treatment Rescriptor. Its drug pipeline has about a dozen candidates, including inhibitor treatments for hepatitis C, cancer, and those pesky rhinoviruses, the most frequent cause of colds. Its development partners include Immune Response, Ibis Therapeutics, ViroLogic, and Pharmaceutical Product Development. The company is a subsidiary of Pfizer.
COMPETITION |
 |
Abbott Laboratories (ABT)
GlaxoSmithKline plc (GSK)
Merck & Co., Inc. (MRK)
|
 |
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: June
1998 Sales (mil.): 466.50
1-Yr. Sales Growth: 253.1%
Employees: 991
Revenue per employee: $470,736.63
KEY PEOPLE |
 |
Barry D. Quart
CEO
Steven S. Cowell
CFO
CONTACT INFO |
 |
10350 N. Torrey Pines Rd., Ste. 100
La Jolla, CA 92037
US
Phone: 858-622-3000
Fax: 858-622-3298
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |